SCHEMBL42676

SCHEMBL42676

CC(O)C(NP(=O)=O)C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.39
CA2 P00918 3/20 0.34
CA1 P00915 2/20 0.34
MME P08473 1/20 0.33
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27534148 0.98 TP53 (0.38) TP53CA2CA1MMEALDH1A1
Bicarbonate SCHEMBL28006549 0.98 TP53 (0.38) TP53CA2CA1MMEALDH1A1
Toluene SCHEMBL27765242 0.84 KEAP1 (0.41) CA2CA1MMEALDH1A1
SCHEMBL29858530 0.74 TP53 (0.47) TP53CA2CA1MMEALDH1A1
SCHEMBL12295234 0.72
SCHEMBL21621510 0.72
SCHEMBL312336 0.72
SCHEMBL21242710 0.72
SCHEMBL21673293 0.72
SCHEMBL14819886 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 17939 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122070942-A Implant adhesive and preparation method and application thereof 杭州源囊生物科技有限公司 2026-05-22 CN claimed
WO-2026102249-A1 TNF RECEPTOR SUPERFAMILY AGONIST FUSION POLYPEPTIDES ANKYRA THERAPEUTICS, INC. (US) 2026-05-15 WO claimed
US-12600699-B2 Thiosemicarbazates and uses thereof THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH (US) 2026-04-14 US claimed
EP-4709434-A1 CALCIUM PHOSPHATE POWDER COMPOSITION Biomimetic Innovations Limited (IE) 2026-03-18 EP claimed
US-20260062469-A1 COMPOSITIONS AND METHODS FOR LINEAR AND CONFORMATIONAL SITE-SPECIFIC ANTIBODIES AND METHODS OF MAKING THE SAME ABBRATECH INC (US) 2026-03-05 US claimed
US-20260021177-A1 IMMUNOMODULATORY FUSION PROTEIN-METAL HYDROXIDE COMPLEXES AND METHODS THEREOF MASSACHUSETTS INST TECHNOLOGY (US) 2026-01-22 US claimed
US-12509508-B2 Compositions and methods for linear and conformational site-specific antibodies and methods of making the same ABBRATECH, INC. (US) 2025-12-30 US claimed
US-20250369983-A1 COMPOSITIONS AND METHODS FOR OPTIMIZED IGG PRODUCTION ABBRATECH INC (US) 2025-12-04 US claimed
EP-4656203-A1 COMPOSITIONS AND METHODS FOR OPTIMIZED IGG PRODUCTION Abbratech Inc. (US) 2025-12-03 EP claimed
EP-4634233-A2 CHECKPOINT MODULATORS FOR ENHANCING IMMUNOTHERAPY Dana-Farber Cancer Institute, Inc. (US) 2025-10-22 EP claimed
US-4868287-A ANTIDEPOSIT UNIVERSITY OF SOUTH ALABAMA (US) 1989-09-19 US claimed
US-4866161-A Inhibition of tartar deposition by polyanionic/hydrophobic peptides and derivatives thereof which have a clustered block copolymer structure UNIVERSITY OF SOUTH ALABAMA (US) 1989-09-12 US claimed
EP-0305283-A2 Inhibition of mineral deposition by polyanionic/hydrophobic peptides and derivatives thereof UNIVERSITY OF SOUTH ALABAMA (US) 1989-03-01 EP claimed
EP-0305282-A1 Inhibition of tartar deposition by polyanionic/hydrophobic peptides and derivatives thereof UNIVERSITY OF SOUTH ALABAMA (US) 1989-03-01 EP claimed
EP-0268663-A1 PHOSPHOPEPTIDES. UNIV MELBOURNE (AU) 1988-06-01 EP claimed
WO-1987007615-A1 PHOSPHOPEPTIDES THE UNIVERSITY OF MELBOURNE (AU) 1987-12-17 WO claimed
EP-0166055-A2 Caries inhibition THE UNIVERSITY OF MELBOURNE (AU) 1986-01-02 EP claimed
EP-0073210-A4 CARIES INHIBITION. UNIV MELBOURNE (AU) 1985-06-10 EP claimed
EP-0073210-A1 CARIES INHIBITION. UNIV MELBOURNE (AU) 1983-03-09 EP claimed
WO-1982003008-A1 CARIES INHIBITION REYNOLDS ERIC CHARLES 1982-09-16 WO claimed